JWH-x Synthetic Cannabinoids Cannabinoid Research

JWH-x Synthetic Cannabinoids Research Dashboard

81

Primary Studies

96

Related Studies

177

Total Studies

Clinical Studies

0

Clinical Meta-analyses

1

Double-blind Clinical Trials

3

Clinical Trials

Pre-Clinical Studies

21

Meta-analyses/Reviews

39

Animal Studies

17

Laboratory Studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 177 studies associated with JWH-x Synthetic Cannabinoids.

Here is a small sampling of JWH-x Synthetic Cannabinoids studies by title:


Components of the JWH-x Synthetic Cannabinoids Research Dashboard

  • Top medical conditions associated with JWH-x Synthetic Cannabinoids
  • Proven effects in clinical trials for JWH-x Synthetic Cannabinoids
  • Receptors associated with JWH-x Synthetic Cannabinoids
  • Individual study details for JWH-x Synthetic Cannabinoids

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - JWH-x Synthetic Cannabinoids

Description of JWH-x Synthetic Cannabinoids

The JWH group of compounds is named after the organic chemist John William Huffman (1932–2022). Huffman and his team have developed over 400 synthetic cannabinoid compounds most of which are used to study the endocannabinoid system (ECS) and its potential for medicinal application. However, members of the JWH series contain a number of compounds that have been used to produce "synthetic cannabinoids" such as "Spice", or "K2," which have been implemented in a number of well publicized overdoses and fatalities. As such, many of these compounds are banned in a number of countries such as China, Australia, or Ireland.


Due to their clinical relevance we focus here on two members of the JWH family i.e., JWH-018 and JWH-133.


Other members of this group that have been researched in the context of potential medical applications include: JWH-122 (full agonist at CB1 and CB2), which will also be listed in the primary and related study list accordingly.

Other Names:

JWH Family Synthetic Cannabinoids

JWH-018


Molecular Formula: C24H23NO


IUPAC Name: naphthalen-1-yl-(1-pentylindol-3-yl)methanone




JWH-133


Molecular Formula: C22H32O


IUPAC Name: (6aR,10aR)-6,6,9-trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene


Source–PubChem

JWH-x Synthetic Cannabinoids Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

JWH-x Synthetic Cannabinoids Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.